Award
National Cancer Institute 5F30CA306319-02
Dissecting a novel role of FAK in modulating immunity during metastatic reactivation and progression
Recipient
Columbia University Health Sciences
Award Amount
$52,068.00
Ceiling
$52,068.00
Awarded
July 30, 2026
Identifier
5F30CA306319-02
Award for research on the role of FAK in immune modulation during metastatic cancer progression, aiming to develop new therapies.
Description
The project focuses on the role of focal adhesion kinase (FAK) in immune regulation during metastatic reactivation. It involves genetic validation experiments, CRISPR-based approaches, and testing of therapeutic strategies to develop novel therapeutic approaches to reduce suffering in patients with metastatic relapse. The research is conducted at Columbia University Irving Medical Center.